Fusing the neck’s top two vertebrae can prevent repeat strokes in children with bow hunter syndrome, a rare condition that affects a handful of U.S. pediatric patients each year, UT Southwestern researchers suggest in a recent study

UT Southwestern Medical Center will lead the nation’s first study of suicide prevention for LGBTQ+ young adults – a group at higher risk for depression and suicide

UT Southwestern Medical Center has been selected as the nation’s first academic medical center to participate in the American Chemical Society (ACS) Bridge program, designed to increase the number of Black, Latino, and Indigenous students earning doctorates in chemistry

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands

Pregnant women who test positive for COVID-19 and their newborn babies have a low risk of developing severe symptoms, according to a new study from UT Southwestern

A small group of brain cells linked in a circuit is responsible for setting off whole-brain seizures in a rare form of epilepsy affected by blood sugar levels, a study led by UT Southwestern researchers suggests

With flu cases on the rise, geriatric specialists at UT Southwestern Medical Center say vaccinations are particularly important this year for people 65 and older who are more at risk from complications than other age groups

Samuel Achilefu, Ph.D., the incoming Inaugural Chair of UT Southwestern Medical Center’s new Department of Biomedical Engineering, is among 100 members elected to the National Academy of Medicine (NAM) this year

Imaging at near-atomic resolution of a key immune protein commonly known as STING has revealed a previously unrecognized binding site that appears to be pivotal for launching immune attacks, UT Southwestern scientists report in a new study

UT Southwestern Medical Center scientists have identified the first two cases of the Beta variant (B.1.351) of COVID-19 infection in North Texas using next-generation sequencing technologies along with targeted PCR testing